Get the latest clinical and surgical news about the Nucleus® Systems, cochlear implant candidacy, reliability, hearing loss and more. Check it out!
In today’s rapidly evolving hearing healthcare landscape, cochlear implant professionals are tasked with more than just delivering sound, they’re guiding patients through life-changing decisions. With multiple systems available, how do […]
Since the first home game consoles in the early 1970s to arcades booming later that decade, video games have become a part of American culture1. They enable connections across homes, counties, states […]
Optimizing long-term hearing outcomes begins with understanding how electrode design and placement influence cochlear implant (CI) performance. Recent innovations emphasize the critical role of the electrode-neural interface, with slim perimodiolar […]
Getting a sound processor replacement can be an exciting and anticipated occasion for your patients. Did you know there is an option for your patients to receive their new Cochlear™ Nucleus® or […]
Hearing preservation (HP) and protection of cochlear structures are essential for optimal patient outcomes post cochlear implantation. Contrary to earlier assumptions around hearing preservation with the Contour Advance, surgeons have […]
As an audiologist, you play a vital role in helping cochlear implant recipients feel confident and connected to their devices. One simple yet powerful way to support that connection? Encourage personalization. […]
Cochlear is now accepting orders for the Nucleus® Nexa® System. Shipments for the Nucleus Nexa System will begin today, August 26, 2025. The recommended earliest day to schedule surgeries is […]
Proper placement of an electrode array is essential for maximizing postoperative performance outcomes with a cochlear implant. Imaging is typically the standard of care for confirming proper electrode placement; however, […]
[LONE TREE, CO, July 8, 2025]: Cochlear Limited (ASX: COH), the global leader in implantable hearing solutions, today announced the U.S Food and Drug Administration (FDA) approval of the Cochlear™ […]
Written by Guest Author, Dr. Abby Meyer, MD, MPH, FAAP Congenital cytomegalovirus (cCMV) infection is the most common congenital infection with an estimated prevalence of approximately 1 in 200 births. […]
End of content
No more pages to load
